The oncogenic activation of MYC, a critical gene in cancer progression, has the potential to identify lung cancer patients who may respond poorly to immunotherapy (ICB). This is the main conclusion of a study recently published ...
Apr 14, 2023
0
54
A large international team of researchers has found that most lung cancers that result from exposure to air pollution are not due to induced mutations but are instead the result of inflammation inciting cells that are more ...
Researchers at the University of Nottingham have helped to develop a new tool called "CanPredict," which is able to identify the people most at risk of developing lung cancer over the next 10 years, and put them forward for ...
Apr 6, 2023
0
44
Most immunotherapies, which aim to boost T cell activity, work poorly in treating estrogen receptor-positive (ER+) breast cancer. Targeting a different type of immune cell called macrophages could be a more effective approach, ...
Mar 16, 2023
0
29
Lung cancer patients with moderate to severe depression are two to three times more likely to have inflammation levels that predict poor survival rates, a new study found.
Mar 6, 2023
0
43
A new study has calculated the economic cost of cancers around the world, helping policymakers allocate resources appropriately and enact policies to curb the increase in cancer-related death and disability.
Feb 24, 2023
0
13
A study from researchers at The University of Texas MD Anderson Cancer Center, published today in Nature Cell Biology, details a previously unexplained type of cell death called disulfidptosis that could open the door for ...
Feb 6, 2023
0
36
Lung cancer claims more lives each year than any other type of cancer worldwide. According to the World Health Organization, an estimated 1.8 million people died of lung cancer in 2020. Current treatments rely on one of two ...
Feb 1, 2023
0
72
Lung cancer is the biggest cause of cancer death in the U.K., but a study by a team of scientists from the University of Southampton has discovered a new way to identify patients who are twice as likely to die from the disease.
Feb 1, 2023
0
56
A team of experts from the University of Barcelona, the University of Zaragoza and Hospital Clínic de Barcelona has found a mechanism of recruitment for tumor-associated cells (cancer-associated fibroblasts or CAFs), which ...
Jan 31, 2023
0
43
